drugset
drugset / Trial / NCT01996605

Efficacy of Spinal Oxytocin in Healthy Volunteers

NCT01996605 ↗

Phase 2 Terminated 20 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of this study is to determine the effect of intrathecal oxytocin on areas and intensity of hyperalgesia and allodynia induced by topical capsaicin.

Timeline

Start
2014-01-02
Primary completion
2022-10-10
Completion
2022-10-10

Outcome

Outcome not reported

Stopped (Enrollment): “Cessation of funding period prior to completion, due to slow recruitment during the pandemic”

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 15 ug Intrathecal
Subject Oxytocin Peptide 150 ug Intrathecal

Indications

No indication recorded.